Items where Author is "Moch, H."

2012

Moch, H. and Blank, P. R. and Dietel, M. and Elmberger, G. and Kerr, K. M. and Palacios, J. and Penault-Llorca, F. and Rossi, G. and Szucs, T. D.. (2012) Personalized cancer medicine and the future of pathology. Virchows Archiv, Vol. 460. pp. 3-8.

2011

Butsch, R. and Lukas Waelti S., and Schaerer, S. and Braun, J. and Korol, D. and Probst-Hensch N., and Moch, H. and Kurrer, M.. (2011) Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma. Leukemia & lymphoma, Vol. 52, H. 7. pp. 1230-1238.

2010

Sutter, R. and Shakhova, O. and Bhagat, H. and Behesti, H. and Sutter, C. and Penkar, S. and Santuccione, A. and Bernays, R. and Heppner, F. L. and Schüller, U. and Grotzer, M. and Moch, H. and Schraml, P. and Marino, S.. (2010) Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene, Vol. 29, H. 12. pp. 1845-1856.

Riener, M. O. and Fritzsche, F. R. and Soll, C. and Pestalozzi, B. C. and Probst-Hensch N., and Clavien, P. A. and Jochum, W. and Soltermann, A. and Moch, H. and Kristiansen, G.. (2010) Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology, Vol. 56, H. 5. pp. 600-606.

Probst-Hensch N. M., and Steiner, J. H. and Schraml, P. and Varga, Z. and Zurrer-Hardi U., and Storz, M. and Korol, D. and Fehr, M. K. and Fink, D. and Pestalozzi, B. C. and Lutolf, U. M. and Theurillat, J. P. and Moch, H.. (2010) IGFBP2 and IGFBP3 protein expressions in human breast cancer : association with hormonal factors and obesity. Clinical cancer research, Vol. 16, no. 3. pp. 1025-1032.

Albinger-Hegyi A., and Stoeckli, S. J. and Schmid, S. and Storz, M. and Iotzova, G. and Probst-Hensch N. M., and Rehrauer, H. and Tinguely, M. and Moch, H. and Hegyi, I.. (2010) Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). International journal of cancer, Vol. 126, H. 11. pp. 2653-2662.

2009

Issa, R. M. and Lebeau, A. and Grob, T. and Holst, F. and Moch, H. and Terracciano, L. and Choschzick, M. and Sauter, G. and Simon, R.. (2009) Estrogen receptor gene amplification occurs rarely in ovarian cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Vol. 22. pp. 191-196.

Riener, M. O. and Stenner, F. and Liewen, H. and Soll, C. and Breitenstein, S. and Pestalozzi, B. C. and Samaras, P. and Probst-Hensch N., and Hellerbrand, C. and Mullhaupt, B. and Clavien, P. A. and Bahra, M. and Neuhaus, P. and Wild, P. and Fritzsche, F. and Moch, H. and Jochum, W. and Kristiansen, G.. (2009) Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology : official journal of the American Association for the Study of Liver Diseases, Vol. 49, No. 5. pp. 1602-1609.

Balamurugan, K. and Luu, V.-D. and Kaufmann, M. R. and Hofmann, V. S. and Boysen, G. and Barth, S. and Bordoli, M. R. and Stiehl, D. P. and Moch, H. and Schraml, P. and Wenger, R. H. and Camenisch, G.. (2009) Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. Oncogene, Vol. 28. pp. 3274-3285.

Langer, I. and Guller, U. and Hsu-Schmitz, S. F. and Ladewig, A. and Viehl, C. T. and Moch, H. and Wight, E. and Harder, F. and Oertli, D. and Zuber, M.. (2009) Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. European journal of surgical oncology : EJSO : the journal of cancer surgery, Vol. 35. pp. 805-813.

Schraml, P. and Frew, I. J. and Thoma, C. R. and Boysen, G. and Struckmann, K. and Krek, W. and Moch, H.. (2009) Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Vol. 22. pp. 31-36.

Boysen, G. and Wollscheid, B. and Bausch-Fluck, D. and Schraml, P. and Moch, H.. (2009) [Identification of VHL-associated changes in clear cell renal carcinoma: the application of combined genome and expression analyses]. Der Pathologe, Vol. 30, Suppl. 2. pp. 188-192.

2008

Steu, S. and Baucamp, M. and von Dach, G. and Bawohl, M. and Dettwiler, S. and Storz, M. and Moch, H. and Schraml, P.. (2008) A procedure for tissue freezing and processing applicable to both intra-operative frozen section diagnosis and tissue banking in surgical pathology. Virchows Archiv, Vol. 452. pp. 305-312.

Tinguely, M. and Jenni, B. and Knights, A. and Lopes, B. and Korol, D. and Rousson, V. and Curioni Fontecedro, A. and Cogliatti, S. B. and Bittermann, A. G. and Schmid, U. and Dommann-Scherrer, C. and Maurer, R. and Renner, C. and Probst-Hensch, N. M. and Moch, H. and Knuth, A. and Zippelius, A.. (2008) MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer science, Vol. 99, H. 4. pp. 720-725.

Curioni-Fontecedro, A. and Knights, A. J. and Tinguely, M. and Nuber, N. and Schneider, C. and Thomson, C. W. and von Boehmer, L. and Bossart, W. and Pahlich, S. and Gehring, H. and Moch, H. and Renner, C. and Knuth, A. and Zippelius, A.. (2008) MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma. Leukemia, Vol. 22, no. 8. pp. 1646-1648.

Lebeau, A. and Grob, T. and Holst, F. and Seyedi-Fazlollahi, N. and Moch, H. and Terracciano, L. and Turzynski, A. and Choschzick, M. and Sauter, G. and Simon, R.. (2008) Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions. The journal of pathology : an official journal of the Pathological Society of Great Britain and Ireland, Vol. 216. pp. 151-157.

Luu, V. D. and Fischer, B. and von Teichman, A. and Boysen, G. and Mertz, K. and Zimmermann, P. and Moch, H. and Schraml, P.. (2008) [Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma]. Der Pathologe, Vol. 29, Suppl. 2. pp. 303-307.

Struckmann, K. and Mertz, K. and Steu, S. and Storz, M. and Staller, P. and Krek, W. and Schraml, P. and Moch, H.. (2008) pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma. The journal of pathology : an official journal of the Pathological Society of Great Britain and Ireland, Vol. 214. pp. 464-471.

1998

Dellas, A. and Schultheiss, E. and Leivas, M. R. and Moch, H. and Torhorst, J.. (1998) Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer research, Vol. 18, H. 6A. pp. 3991-3998.

1997

Dellas, A. and Schultheiss, E. and Almendral, A. C. and Gudat, F. and Oberholzer, M. and Feichter, G. and Moch, H. and Torhorst, J.. (1997) Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia. International journal of cancer, Vol. 74, H. 4. pp. 421-425.

Dellas, Athanassios and Moch, H. and Schultheiss, E. and Feichter, G. and Almendral, A. C. and Gudat, F. and Torhorst, J.. (1997) Angiogenesis in cervical neoplasia : microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations. Gynecologic oncology, 67 (1). pp. 27-33.